In This Section

AACR Virtual Special Conference:
Tumor Immunology and Immunotherapy

October 19-20, 2020
AACR Virtual Special Conference

Register Now

Conference Cochairs

Timothy A. Chan, Memorial Sloan Kettering Cancer Center, New York, New York
Charles G. Drake
, Columbia University Medical Center, New York, New York
Marcela V. Maus
, Massachusetts General Hospital, Boston, Massachusetts
Arlene H. Sharpe, Harvard Medical School, Boston, Massachusetts

This AACR Virtual Special Conference on Tumor Immunology and Immunotherapy is designed to integrate multidisciplinary facets of basic cancer immunology and immunotherapy to broaden our understanding of ways to harness the immune system to treat cancer. The hallmark of this series is also to encourage the effective exchange of ideas between basic cancer immunologists, non-immunologists, and clinical oncologists in order to develop approaches that translate to outcomes. This year’s program will feature international leaders in the field, who will expand our knowledge of T-cell and non-T-cell therapies; novel combinations; innate and adaptive checkpoints; and defining novel immunotherapy targets. These world-renowned oncologists and researchers will offer their insights on vaccines, neoantigens, oncolytic viruses, synthetic biology and novel approaches to immune engineering, all in the pursuit of understanding tumor evolution and creating better treatments.

Major Supporter

Bristol Myers Squibb

Professional Educational Grant

GlaxoSmithKline
Pfizer

Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available


#AACRtii20